D.E. Shaw & Co’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.4M Hold
1,423,125
0.01% 1322
2025
Q4
$15.2M Hold
1,423,125
0.01% 1424
2025
Q3
$15.1M Hold
1,423,125
0.01% 1375
2025
Q2
$15M Buy
1,423,125
+185,625
+15% +$1.94M 0.01% 1219
2025
Q1
$12.8M Hold
1,237,500
0.01% 1221
2024
Q4
$12.6M Buy
1,237,500
+377,727
+44% +$3.81M 0.01% 1337
2024
Q3
$8.67M Buy
+859,773
New +$8.62M 0.01% 1518

Other funds holding GPAT

D.E. Shaw & Co's GPAT Position: Q1 2026 in Review

D.E. Shaw & Co held its GP-Act III Acquisition Corp (GPAT) position steady in Q1 2026 at 1,423,125 shares worth $15.4M. The position accounts for 0.01% of the portfolio, ranked #1322.

D.E. Shaw & Co first reported a position in GPAT in Q3 2024 and has held it in 7 quarters since. 51 funds tracked by Wall St. Rank hold GPAT as of Q1 2026.

  • D.E. Shaw & Co held 1,423,125 shares of GP-Act III Acquisition Corp worth $15.4M as of Q1 2026.
  • D.E. Shaw & Co left its GP-Act III Acquisition Corp share count unchanged in Q1 2026.
  • GP-Act III Acquisition Corp made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1322 holding.
  • D.E. Shaw & Co first reported a position in GP-Act III Acquisition Corp in Q3 2024 and has held it in 7 quarters since.
  • 51 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.